利奈唑胺治疗耐药结核的研究进展

Progress of linezolid in the treatment of the multi-drug resistant tuberculosis

利奈唑胺是一种新型恶唑烷酮类抗菌药物,在体外对耐多药结核菌有抗菌作用,其临床疗效已得到一系列临床研究证明。本文综述其抗菌作用、临床疗效及不良反应等研究进展。

Linezolid is a new antibacterial agent of oxazolidinone, which has demonstrated antibacterial activity in viro against multi-drug resistant tuberculosis. Its clinical curative effect has been proved by a number of clinical data. This review summarizes the antibacterial potency, clinical effect and adverse reactions of linezolid.